Contributors |
|
v | |
Preface |
|
vii | |
Acknowledgments |
|
ix | |
|
I Evaluation of the Patient with Renal Disease |
|
|
1 | (24) |
|
1 Clinical and Laboratory Evaluation of Kidney Disease and Fluid Status |
|
|
3 | (8) |
|
|
|
2 Evaluation of Kidney Structure: Radiology and Biopsy |
|
|
11 | (7) |
|
|
3 Proteinuria and the Nephrotic Syndrome |
|
|
18 | (5) |
|
|
|
23 | (2) |
|
|
|
II Glomerular and Tubulointerstitial Diseases and Vasculitis |
|
|
25 | (58) |
|
5 Diabetic Kidney Disease |
|
|
27 | (5) |
|
|
|
32 | (2) |
|
|
|
34 | (11) |
|
|
|
8 Renal Involvement in Systemic Lupus Erythematosus |
|
|
45 | (6) |
|
|
|
|
51 | (6) |
|
|
|
10 Renal Involvement in Thrombotic Microangiopathy and Scleroderma |
|
|
57 | (4) |
|
|
|
11 Monoclonal Gammopathy-Related Kidney Diseases |
|
|
61 | (11) |
|
|
12 Tubulointerstitial Nephritis |
|
|
72 | (5) |
|
|
13 Renal Involvement in Viral Diseases and HIV |
|
|
77 | (6) |
|
|
|
83 | (22) |
|
14 Renal Cystic and Other Hereditary Disease |
|
|
85 | (6) |
|
|
15 Genetic Glomerular and Tubular Disorders |
|
|
91 | (8) |
|
|
|
16 Genetic Forms of Hypertension |
|
|
99 | (6) |
|
|
|
|
IV Disorders of Water, Electrolytes, and Acid-Base Regulation |
|
|
105 | (46) |
|
17 Dysnatremia and Disorders of Water Balance |
|
|
107 | (10) |
|
|
|
|
117 | (12) |
|
|
|
|
129 | (9) |
|
|
|
20 Calcium, Phosphorus, and Magnesium Disorders |
|
|
138 | (13) |
|
|
V Disease of the Urinary Collecting System |
|
|
151 | (20) |
|
|
153 | (9) |
|
|
|
22 Urinary Tract Infections |
|
|
162 | (9) |
|
|
|
171 | (28) |
|
23 Approach to the Hypertensive Patient |
|
|
173 | (7) |
|
|
24 Urgent, Emergent, Resistant and Secondary Forms of Hypertension |
|
|
180 | (12) |
|
|
25 Hypertension and Renal Disease in Pregnancy |
|
|
192 | (7) |
|
|
VII Drug Use and the Kidney |
|
|
199 | (36) |
|
26 Drug Dosing in Renal Insufficiency |
|
|
201 | (16) |
|
|
27 Nephrotoxic Drugs, Contrast Nephropathy - and Renal Protective Strategies |
|
|
217 | (5) |
|
|
|
28 Immunosuppressive Agents for Kidney Transplantation |
|
|
222 | (9) |
|
|
|
29 Oncology Drugs and the Kidney |
|
|
231 | (4) |
|
|
VIII Drug Use in Hypertension and Volume Overload |
|
|
235 | (34) |
|
30 Diuretic Drugs and Resistance |
|
|
237 | (11) |
|
|
|
31 Alpha- and Beta-Blockers and Sympatholytics |
|
|
248 | (6) |
|
|
32 Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Renin Antagonists and Mineralocorticosteroid Receptor Antagonists |
|
|
254 | (7) |
|
|
33 Calcium Channel Blockers and Other Vasodilators |
|
|
261 | (5) |
|
|
|
|
266 | (3) |
|
|
IX Diagnosis and Management of Renal Failure |
|
|
269 | (56) |
|
|
271 | (8) |
|
|
|
36 Chronic Kidney Disease |
|
|
279 | (8) |
|
|
|
37 Cardiovascular Complications of Chronic Kidney Disease |
|
|
287 | (8) |
|
|
|
38 Renal Disease in Patients with Liver Disease |
|
|
295 | (6) |
|
|
|
39 Anemia of Chronic Kidney Disease |
|
|
301 | (4) |
|
|
40 Nutrition in Renal Failure |
|
|
305 | (9) |
|
|
|
|
314 | (11) |
|
|
|
325 | (28) |
|
42 Hemodialysis and Continuous Therapies |
|
|
327 | (10) |
|
|
|
|
337 | (5) |
|
|
|
342 | (4) |
|
|
|
346 | (7) |
|
|
|
|
353 | (14) |
|
46 The Evaluation for Kidney Transplantation |
|
|
355 | (3) |
|
|
47 Medical Complications Following Kidney Transplantation |
|
|
358 | (9) |
|
|
XII Medical Reimbursement and Economics of Nephrology |
|
|
367 | (8) |
|
48 Medical Reimbursement and the Economics of Nephrology Practice |
|
|
369 | (6) |
|
|
Index |
|
375 | |